Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- NEU-411Phase 21 trial
Neuron23 Inc. · Parkinson Disease, Parkinson, Idiopathic Parkinson Disease
- NG101mPhase 21 trial
NeuGATE Theranostics · Glioblastoma Multiforme
- NGGT001Phase 21 trial
NGGT (Suzhou) Biotechnology Co., Ltd. · Bietti Crystalline Corneoretinal Dystrophy
- NGI226Phase 21 trial
Novartis · Achilles Tendinopathy
- NGM120Phase 21 trial
NGM Biopharmaceuticals, Inc · Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
- NH102Phase 21 trial
Jiangsu Nhwa Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)
- NHS7108Phase 21 trial
Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality
- NHT102Phase 21 trial
Nob Hill Therapeutics, Inc. · NSCLC (Advanced Non-small Cell Lung Cancer)
- NIDO-361Phase 21 trial
Nido Biosciences, Inc. · Spinal and Bulbar Muscular Atrophy, Kennedy's Disease
- NimacimabPhase 21 trial
Skye Bioscience, Inc. · Obesity
- NIO752Phase 21 trial
Novartis · Progressive Supranuclear Palsy, Corticobasal Degeneration, Frontotemporal Lobar Degeneration
- NKT2152Phase 21 trial
Roche (Genentech) · Advanced Liver Cancers
- NKTR-255Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
- NLS-133Phase 21 trial
Next Life Sciences · Male Contraception, Semen Volume, Sperm Motility
- NN2802Phase 21 trial
Novelty Nobility, Inc. · Healhty, Chronic Spontaneous Urticaria (CSU)
- NNC0662-3168Test product-APhase 21 trial
Novo Nordisk · Overweight, Obesity, Type 2 Diabetes Mellitus
- NOC-110taplucainiumPhase 21 trial
Nocion Therapeutics · Refractory or Unexplained Chronic Cough
- NOE-115Phase 21 trial
Noema Pharma AG · Menopause Syndrome, Menopause, Hot Flashes
- NoNO-42Phase 21 trial
NoNO Inc. · Acute Ischemic Stroke
- NORA520Phase 21 trial
TWi Biotechnology, Inc. · Depression, Postpartum, Postpartum Depression, Post-partum Depression
- NP137Phase 21 trial
NETRIS Pharma · Endometrial Carcinoma, Cervix Carcinoma
- NPT 2042Phase 21 trial
NeuroPro Therapeutics, Inc. · Epilepsy, Generalized, Epilepsy, Absence
- NRC-2694-APhase 21 trial
NATCO Pharma Ltd. · Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
- NS-050NCNP-03Phase 21 trial
NS Pharma, Inc. · Duchenne Muscular Dystrophy
- NS-136Phase 21 trial
NeuShen Therapeutics · Schizophrenia(Acute)
- NS-229Phase 21 trial
NS Pharma, Inc. · Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
- NS101Phase 21 trial
Neuracle Science Co., LTD. · Seneorineural Deafness, Sudden Sensorineural Hearing Loss
- NSC001Phase 21 trial
NSC-Therapeutics · Alzheimer Disease
- NSI-8226Phase 21 trial
Uniquity One (UNI) · Asthma
- NST-1024Phase 21 trial
NorthSea Therapeutics B.V. · High Triglycerides
- NST-6179Phase 21 trial
NorthSea Therapeutics B.V. · Intestinal Failure Associated Liver Disease
- NTB003Phase 21 trial
Nanjing Chia-tai Tianqing Pharmaceutical · Thyroid Eye Disease
- NTRX-07MDA7Phase 21 trial
NeuroTherapia, Inc. · Alzheimer Disease, Mild Cognitive Impairment
- NTS-521Phase 21 trial
NeuroTrauma Sciences, LLC · Acute Ischemic Stroke
- NTS071Phase 21 trial
Nutshell Therapeutics (Shanghai) Co., LTD. · Advanced Solid Tumors
- NTX-1472Phase 21 trial
Newleos Therapeutics, Inc. · Social Anxiety Disorder (SAD)
- NUV-1511Phase 21 trial
Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NV-5138SPN820Phase 21 trial
Navitor Pharmaceuticals, Inc. · Treatment Resistant Depression
- NV01-A02Phase 21 trial
Neuroventi Inc. · Autism Spectrum Disorder (ASD
- NVG-2089Phase 21 trial
Nuvig Therapeutics, Inc. · Immune Thrombocytopenia (ITP)
- NX210cPhase 21 trial
Axoltis Pharma · Amyotrophic Lateral Sclerosis
- NXC736Phase 21 trial
NEXTGEN Bioscience · Alopecia Areata
- NYX-458Phase 21 trial
Aptinyx · Mild Cognitive Impairment, Mild Dementia, Parkinson Disease
- OATD-01Phase 21 trial
Molecure S.A. · Pulmonary Sarcoidosis
- OBI-902Phase 21 trial
OBI Pharma, Inc · Advanced Solid Tumor
- OBI-992Phase 21 trial
OBI Pharma, Inc · Advanced Solid Tumor
- OBX-115Phase 21 trial
Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma
- OCU400Phase 21 trial
Ocugen · Retinitis Pigmentosa, Leber Congenital Amaurosis
- OD-07656Phase 21 trial
Odyssey Therapeutics, Inc. · Ulcerative Colitis (UC), UC - Ulcerative Colitis
- ODM-216Phase 21 trial
Orion Corporation, Orion Pharma · Advanced Solid Tumors Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.